Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Obicetrapib calcium by NewAmsterdam Pharma Company for Heterozygous familial hypercholesterolemia (heFH): Likelihood of Approval
Obicetrapib calcium is under clinical development by NewAmsterdam Pharma Company and currently in Phase III for Heterozygous familial hypercholesterolemia (heFH)....